End-of-day quote
Other stock markets
|
||
- SEK | - |
Business Summary
Sales per Business
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Arfolitixorin
100.0
%
| 13 | 100.0 % | 1 | 100.0 % | -94.37% |
Sales per region
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Asia
100.0
%
| 13 | 100.0 % | 1 | 100.0 % | -94.37% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Petter Lindqvist
CEO | Chief Executive Officer | 72 | Jan. 08 |
Magnus Hurst
DFI | Director of Finance/CFO | 68 | Jan. 09 |
Roger Tell
CTO | Chief Tech/Sci/R&D Officer | 59 | 19-01-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Lars Erik Lind
CHM | Chairman | 83 | - |
Sten Nilsson
BRD | Director/Board Member | 76 | Jan. 03 |
Alain Herrera
BRD | Director/Board Member | 74 | 17-12-31 |
79 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 161,515,440 | 107,964,057 ( 66.84 %) | 0 | 66.84 % |
Company contact information
Isofol Medical AB
Biotech Center Arvid Wallgrens Backe 20
413 46, Gothenburg
+46 3 17 97 22 80
http://www.isofol.seSector
Sales per region
1st Jan change | Capi. | |
---|---|---|
+6.87% | 72.87B | |
+34.51% | 10.31B | |
+40.84% | 5.23B | |
-18.53% | 4.62B | |
+12.65% | 3.52B | |
+27.58% | 2.31B | |
-39.96% | 1.78B | |
-45.87% | 1.69B | |
-0.50% | 1.64B |
- Stock Market
- Equities
- ISOFOL Stock
- Stock
- Company Isofol Medical AB (publ)